Hawaii Clinical Trials
Browse actively recruiting clinical trials with research sites in Hawaii. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in Hawaii
- Connect for Cancer Prevention Study (Connect)NCT04609072National Cancer Institute (NCI)CancerHonolulu, HI
- Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN StudyNCT05987241PHASE2, PHASE3National Cancer Institute (NCI)Muscle Invasive Bladder Urothelial CarcinomaHonolulu, HI
- Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the LungNCT05058651PHASE2, PHASE3National Cancer Institute (NCI)Advanced Extrapulmonary Neuroendocrine CarcinomaHonolulu, HI
- Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)NCT06317649PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaHonolulu, HI
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyNCT05136196PHASE2National Cancer Institute (NCI)Clinical Stage III Cutaneous Melanoma AJCC v8Honolulu, HI
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNCT06172296PHASE3National Cancer Institute (NCI)Ganglioneuroblastoma, NodularHonolulu, HI
- A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell HistiocytosisNCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisHonolulu, HI
- A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)NCT06124157PHASE2National Cancer Institute (NCI)B Acute Lymphoblastic LeukemiaHonolulu, HI
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyNCT05774951PHASE3AstraZenecaBreast Cancer, Early Breast CancerHonolulu, HI
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7NCT04613596PHASE2, PHASE3Mirati Therapeutics Inc.Advanced Non-Small Cell Lung CancerHonolulu, HI
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)NCT05564390PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaHonolulu, HI
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisNCT07225504PHASE3Novartis PharmaceuticalsSecondary Progressive Multiple Sclerosis (SPMS)Honolulu, HI
Popular conditions in Hawaii
Frequently asked questions
- How do I find clinical trials in Hawaii?
- Corterve aggregates actively recruiting clinical trials with sites in Hawaii from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in Hawaii free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in Hawaii?
- Hawaii research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.